Evidence map›Paper›PMID 39333588›Full record

ArticleNature communications2024

The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity.

Pilar Garcia-Vello, Hanne L P Tytgat, Janneke Elzinga, Matthias Van Hul, Hubert Plovier, Marta Tiemblo-Martin, Patrice D Cani, Simone Nicolardi, Marco Fragai, Cristina De Castro and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Gut microbes · 2026
    Article
  2. Article
  3. Enteric-colonizedGut microbes · 2026
    Article
  4. Review
  5. Gut microbes · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  17. Review
  18. Review
  19. Article
  20. Pterostilbene-mediated microbiota shifts: Implications and opportunities.Journal of traditional and complementary medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pilar Garcia-Vello *Department of Chemical Sciences, University of Naples Federico II, Napoli, Italy.ORCID 0000-0001-7124-1790
Hanne L P Tytgat *Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.ORCID 0000-0001-6270-2110
Janneke ElzingaLaboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.ORCID 0000-0002-4819-9499
Matthias Van HulLouvain Drug Research Institute, Metabolism and Nutrition Research group, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.
Hubert PlovierLouvain Drug Research Institute, Metabolism and Nutrition Research group, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.
Marta Tiemblo-MartinDepartment of Chemical Sciences, University of Naples Federico II, Napoli, Italy.
Patrice D CaniLouvain Drug Research Institute, Metabolism and Nutrition Research group, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.ORCID 0000-0003-2040-2448
Simone NicolardiCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-8393-1625
Marco FragaiMagnetic Resonance Center (CERM), CIRMMP and Department of Chemistry "Ugo Schiff", University of Florence, Florence, Italy.ORCID 0000-0002-8440-1690
Cristina De CastroDepartment of Chemical Sciences, University of Naples Federico II, Napoli, Italy.ORCID 0000-0002-5147-1756
Flaviana Di LorenzoDepartment of Chemical Sciences, University of Naples Federico II, Napoli, Italy.
Alba SilipoDepartment of Chemical Sciences, University of Naples Federico II, Napoli, Italy.ORCID 0000-0002-5394-6532
Antonio MolinaroDepartment of Chemical Sciences, University of Naples Federico II, Napoli, Italy. molinaro@unina.it.ORCID 0000-0002-3456-7369
Willem M de VosLaboratory of Microbiology, Wageningen University, Wageningen, The Netherlands. willem.devos@wur.nl.ORCID 0000-0002-0273-3166

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) AdG 250172
6 · The paper itself

Abstract

The cell-envelope of Gram-negative bacteria contains endotoxic lipopolysaccharides (LPS) that are recognized by the innate immune system via Toll-Like Receptors (TLRs). The intestinal mucosal symbiont Akkermansia muciniphila is known to confer beneficial effects on the host and has a Gram-negative architecture. Here we show that A. muciniphila LPS lacks the O-polysaccharide repeating unit, with the resulting lipooligosaccharide (LOS) having unprecedented structural and signaling properties. The LOS consists of a complex glycan chain bearing two distinct undeca- and hexadecasaccharide units each containing three 2-keto-3-deoxy-D-manno-octulosonic acid (Kdo) residues. The lipid A moiety appears as a mixture of differently phosphorylated and acylated species and carries either linear or branched acyl moieties. Peritoneal injection of the LOS in mice increased higher gene expression of liver TLR2 than TLR4 (100-fold) and induced high IL-10 gene expression. A. muciniphila LOS was found to signal both through TLR4 and TLR2, whereas lipid A only induced TLR2 in a human cell line. We propose that the unique structure of the A. muciniphila LOS allows interaction with TLR2, thus generating an anti-inflammatory response as to compensate for the canonical inflammatory signaling associated with LOS and TLR4, rationalizing its beneficial host interaction.

Indexed as

AkkermansiaLipopolysaccharidesSignal TransductionToll-Like Receptor 2Toll-Like Receptor 4AnimalsFemaleGastrointestinal MicrobiomeHumansInterleukin-10Lipid ALiverMiceMice, Inbred C57BLSymbiosisInterleukin-10Lipid Alipid-linked oligosaccharidesLipopolysaccharidesToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID39333588
PMCPMC11436972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.